Insideprecisionmedicine.com·2 min read·medium

Pancreatic Cancer Vaccine Triggers Immune Response Before Tumors Develop - Inside Precision Medicine

C
Clara Rodriguez Fernandez
Pancreatic Cancer Vaccine Triggers Immune Response Before Tumors Develop - Inside Precision Medicine
AI Summary

A Phase I clinical trial has shown that a new vaccine can trigger an immune response in patients at high risk for pancreatic cancer before tumors form. The findings were recently published in the journal Cancer Discovery.

Results from a Phase I clinical trial show early promise for a vaccine designed to prevent pancreatic cancer in people at high risk of developing the disease. Published in Cancer Discovery, the findi…

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in